Physician profile
Aaron Elkin
NPI 1477736288
$2,884.86
in general payments reported to CMS, 2019-2025
13 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $46.49 · 2021: $547 · 2022: $1,340 · 2023: $177 · 2024: $195 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $1,152.93 | 2022 | |
| Hologic Sales and Service, LLC | $508.65 | 2019-2025 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Gynesonics, INC. | $473.30 | 2021-2022 | |
| Abbvie INC. | $193.81 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $121.83 | 2025 | |
| Pfizer INC. | $120.10 | 2021-2024 | |
| Astellas Pharma US INC | $93.50 | 2024-2025 | Veozah |
| Lupin INC. | $73.64 | 2019-2021 | |
| Therapeuticsmd, INC. | $50.09 | 2019-2022 | |
| Evofem Biosciences, INC. | $36.14 | 2024 | |
| Aspira Women'S Health INC | $30.48 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $30.39 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Elkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.